Skip to main content
Clinical Trials/CTRI/2022/01/039842
CTRI/2022/01/039842
Recruiting
未知

Patient reported outcomes (PRO) of patients treated with Proton therapy for Prostate cancer: A prospective registry - Pro3 registry

Apollo Proton Cancer Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Apollo Proton Cancer Centre
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Apollo Proton Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • 1\. Age more than 18 years
  • 2\. Patient with biopsy proven diagnosis of prostate cancer treated with proton beam at the Apollo Proton Cancer Centre.
  • 3\. Patient / guardian, who have the ability to understand and be willing to sign a written informed consent document

Exclusion Criteria

  • Patients or legal guardians who are not willing sign informed consent document

Outcomes

Primary Outcomes

Not specified

Similar Trials